Serum test identifies patients deriving benefit from CPIs 199 5 Supplementary Table S9: Classification concordance (sensitive vs. intermediate vs. resistant). Run2 Resistant (n=37) Intermediate (n=30) Sensitive (n=31) Run1 Resistant (n=40) 34 6 0 Intermediate (n=22) 2 19 1 Sensitive (n=36) 1 5 30 Supplementary Table S10: Classification concordance (resistant vs. not resistant). Run2 Resistant (n=37) Not resistant (n=61) Run1 Resistant (n=40) 34 6 Not resistant (n=58) 3 55 Supplementary Table S11: Classification concordance (sensitive vs. not sensitive). Run2 Not sensitive (n=67) Sensitive (n=31) Run1 Not sensitive (n=62) 61 1 Sensitive (n=36) 6 30 3. Association of response with test classification Supplementary Table S12: Response by test classification in the development cohort. Resistant (n=41) Intermediate (n=43) Sensitive (n=32) n (%) n (%) n (%) Response CR 0 (0) 0 (0) 1 (3) PR 4 (10) 4 (9) 8 (25) SD 1 (2) 11 (26) 7 (22) PD 35 (85) 21 (49) 9 (28) NA 1 (2) 7 (16) 7 (22)
RkJQdWJsaXNoZXIy MTk4NDMw